Contribution of nationwide genome screening in Japan (LC-SCRUM-Japan) to the development of precision medicine for non-small cell lung cancer.Takashi Seto, Kōichi Goto, Takuma Yokoyama et al.|Journal of Clinical Oncology|2018Cited by 7
Expressions of KLF2 and chemokine receptor CCR7 in pulmonary adenocarcinoma.Meiji Itakura, Toshihiko Iizasa, Masato Shingoji|Journal of Clinical Oncology|2012Cited by 0